Chemycal has been acquired by 3E
Learn MoreChemycal has been acquired by 3E
Learn More
Discover how Chemycal PRO helps you boosting your regulatory monitoring:
The minutes of the meeting of the Working Group on Cosmetic Ingredients held on 14-15 September 2023 includes the following item(s):
2. List of points discussed
2.1 New mandates or information from DG GROW
No new mandate was adopted.
2.2 Draft opinions discussed
The following dossiers have been discussed:
• TiO2 scientific advice in oral and inhalation cosmetic products: the SCCS received clarifications from the Applicant. The draft scientific advice was discussed, and tasks were allocated to members. The preliminary version is planned for adoption during the plenary meeting in October.
• Triphenylphosphate (TPP): a request for information has been prepared for the Applicant. The draft preliminary Opinion will be further discussed in the next meeting.
• Hexylsalicylate: CMR2 exemption: a request for information has been prepared for the Applicant. The draft preliminary Opinion will be further discussed in the next meeting and is planned to be presented to the plenary members in October.
• Acetylated vetiver oil (AVO) Subm. IV on acute inhalation: tasks were allocated to the members and the draft preliminary Opinion will be discussed in the next meeting.
• Benzophenone – 1: tasks were allocated to the members and a request for information has been prepared for the Applicant.
• Benzophenone - 4: tasks were allocated to the members and a request for information has been prepared for the Applicant.
• Aluminium 2023 updated use concentration: the SCCS sent a clarification to the Applicant. It will be discussed the next WG meeting.
2.3 Comments on opinions
• Methylsalicylate: the SCCS response to the comment received and the final version of the scientific advice were adopted by written procedure on 14 September. The final document will be published here: SCCS - Opinions (europa.eu)
• Silver zinc zeolite: one comment has been received and discussed and a request to Applicant will be prepared before finalising the Opinion.
• 12th revision of the Notes of Guidance: a corrigendum is under preparation for adoption in plenary meeting in October.
• Methylparaben: comments received during the commenting period are under consideration during the finalisation of the Opinion.
• Butylparaben: comments received during the commenting period are under consideration during the finalisation of the Opinion.
• Benzyl salicylate: comments received during the commenting period are under consideration during the finalisation of the Opinion.
• Zn salts in oral products (submission II): no comment was received on the preliminary Opinion. The final text will be adopted during the plenary meeting in October.
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions